论文部分内容阅读
目的探讨卵巢非霍奇金淋巴瘤(NHL)的诊断、治疗及预后。方法从1995年10月~2005年8月对11例卵巢NHL进行手术、化疗及放疗。化疗采用CHOP、mBACOD、MACOP及PROMACE-CYtaBOM方案,3例行骨髓移植,接受超大剂量化疗。结果1例术后拒绝化疗,出院后失访;1例骨髓移植,接受超大剂量的化疗后12月无复发;9例随访至死亡。最短生存5月,最长生存26月,中位生存13月。结论卵巢NHL预后差,应采取综合治疗。
Objective To investigate the diagnosis, treatment and prognosis of ovarian non-Hodgkin’s lymphoma (NHL). Methods From October 1995 to August 2005, 11 cases of ovarian NHL underwent surgery, chemotherapy and radiotherapy. Chemotherapy with CHOP, mBACOD, MACOP and PROMACE-CYtaBOM program, 3 cases of bone marrow transplantation, receiving large doses of chemotherapy. Results One patient was refused chemotherapy after operation and was discharged after discharge. One patient underwent bone marrow transplantation without recurrence after 12 months of chemotherapy. Nine patients were followed up until death. The shortest survival in May, the longest survival in 26 months, the median survival of 13 months. Conclusions Ovary NHL has poor prognosis and should be treated comprehensively.